Who owns Tempest Therapeutics Inc?
- Ticker: TPST
- CUSIP Number: 87978u207
Tip: Access positions for across all investors
Analyze quarterly positions in Tempest Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tempest Therapeutics stock
Who bought or sold Tempest Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 234k | $384k | 100% | Mar 2026 |
|
| Sabby Management | 179k | $513k | 100% | Dec 2025 |
|
| Vanguard Group | 163k | $466k | 0% | Dec 2025 |
|
| Geode Capital Management | 87k | $143k | 97% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 69k | $113k | 100% | Mar 2026 |
|
| BlackRock | 39k | $64k | 0% | Mar 2026 |
|
| FMR | 33k | $95k | 0% | Dec 2025 |
|
| Northern Trust | 14k | $40k | 100% | Dec 2025 |
|
| Dimensional Fund Advisors | 11k | $19k | 0% | Mar 2026 |
|
| UBS Group | 4.5k | $7.4k | -74% | Mar 2026 |
|
| Morgan Stanley | 2.1k | $3.4k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 1.6k | $4.6k | -3% | Dec 2025 |
|
| Tower Research Capital | 1.3k | $3.8k | 100% | Dec 2025 |
|
| Atlantic Trust | 1.1k | $3.1k | 135% | Dec 2025 |
|
| Federation des caisses Desjardins du Quebec | 292.00 | $478.996800 | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 239.00 | $686.001700 | 100% | Dec 2025 |
|
| Vanguard Global Advisers | 168.00 | $276.007200 | 100% | Mar 2026 |
|
| SBI Securities | 56.00 | $92.002400 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 27.00 | $0 | 100% | Mar 2026 |
|
| Parallel Advisors | 18.00 | $30.000600 | 0% | Mar 2026 |
|
| Citigroup | 8.00 | $13.000000 | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $5.000100 | 0% | Mar 2026 |
|
Who sold out of Tempest Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DRW Holdings | Dec 2025 | 10k | $30k |